CCN Number 4/2018
ePaper
CCN Number 4/2018
PDF (23 MB)
Number 4/2018
AF-ALERT: Active Digital Prompt to Prescribe OAC in
Patients with Atrial Fibrillation
BIONYX: Orsiro vs. Resolute Onyx DES
COAPT: MitraClip in Patients with Heart Failure and
Secondary Mitral Insufficiency
DECLARE: Dapagliflozin in Type 2 Diabetes Mellitus
NEOPRO: TAVI with the New Self-Expanding
Evolut PRO and Acurate neo Valves
OAC-ALONE: OAC as Long-Term Monotherapy in Patients with
CAD and AF
ODYSSEY OUTCOMES COSTS: Cost Effectiveness of Alirocumab
PIONEER HF: Angiotensin Receptor-Neprilysin Inhibition in
Acute Heart Failure
REDUCE-FMR: The Carillon System for Functional
Mitral Insufficiency
SOLVE-TAVI: Self-Expanding vs. Balloon-Expandable Valves and
General Anaesthesia vs. Local Anaesthesia/Sedation in TAVI
KOLUMNEN
- Diabetes: Management of Hyperglycemia in Type 2 Diabetes with
Cardiovascular Disease: ADA – EASD 2018 Consensus Report
- Myocardial Ischemia: FFR or iFR Measurement will be a Billable
Service for Accredited Physicians in Germany Starting Oct. 1, 2018
- Sports Medicine: Genetics or Fitness – Which is More Decisive?
- Heart Failure: Influence of Atrial Fibrillation on
Heart Failure Prognosis
CCN Number 3/2018
ePaper
CCN Number 3/2018
PDF (23 MB)
Number 3/2018
ART: Single vs. Double Mammary Artery in
Coronary Bypass Surgery
BASKET-SMALL 2: Drug-Coated Balloons (DCB) vs.
Drug-Eluting Stents (DES) for Small Coronary Arteries
CULPRIT-SHOCK: PCI for Multi-Vessel Disease in
Cardiogenic Shock – 1-year results
DIGITAL HF: Detection of Atrial Fibrillation is Possible
with a Smartphone
GLOBAL LEADERS: Ticagrelor Monotherapy After
Coronary Stent Implantation?
MITRA.fr: MitraClip for Secondary Mitral Insufficiency is not
Superior to Optimal Medical Therapy
SCOT HEART 5-Years Results: Cardiac CT and Infarct Risk
TIMI-HF 2: Mortality Advantage with Telemonitoring in
Patients with Heart Failure
COLUMNS
- Diabetes: Aspirin Primary Prevention in Diabetes:
The ASCEND Study (A Study of Cardiovascular Events in Diabetes)
- Myocardial Ischemia: How frequent is objective, non-invasive
proof of ischemia prior to an elective coronary angiography?
- Sports Medicine: ESC Hypertension Guideline 2018
- Heart Failure: B-lymphocyte function – a new Biomarker
for Heart Failure?
CCN Number 2/2018
ePaper
CCN Number 2/2018
PDF (43 MB)
Number 2/2018
BIO-RESORT: Comparison of Absorbable with Durable Coating
of DES: 2-Years Results
BIOSOLVE IV: First 1-Year Results of the Magmaris registry study
CABANA: No Advantages of Ablation vs. Medical Therapy
in Atrial Fibrillation
CENTERA-EU: a New Self-Expanding TAVI Valve
CENTURY II: 5-Year Results of the Ultimaster DES with an Absorbable Polymer
GZ-FFR: Randomized Pilot Study of PCI vs. OMT in Stable CAD
with Equivocal FFR
ORBITA: FFR and iFR do not Correlate with Exercise Tolerance
after PCI
SORT OUT VIII: Randomized Comparison of the Synergy with the Biomatrix DES
SPYRAL HTN - ON MED: Renal Denervation for Arterial Hypertension with Antihypertensive Medication
SYNTAX III REVOLUTION: Can Coronary CT Angiography Replace Cardiac Catheterisation?
COLUMNS
- Diabetes: Healthy and Obese? MESA Study on Obesity,
Metabolic Syndrome and Cardiovascular Risk
(Multi-Ethnic Study of Atherosclerosis)
- Myocardial Ischemia: Myocardial Injury after Non-cardiac Surgery
(MINS) – Mostly Silent, but Associated with Increased Mortality
- Sports Medicine: Impact of Healthy Lifestyle Factors
on Life Expectancies in the US Population
- Heart Failure: H2FPEF Score for Diagnosis of Diastolic Heart Failure
CCN Number 1/2018
ePaper
CCN Number 1/2018
PDF (43 MB)
Number 1/2018
GEISINGER HIS BUNDLE PACING: Better Outcome
with His Bundle Stimulation
MANAGE: Dabigatran Improves Prognosis of MINS
MSTOPS: Intensified Monitoring Identifies more Atrial Fibrillation
NOTION 5-year: All-Comer Study to Compare TAVI with Surgical Aortic Valve Replacement (SAVR)
ODYSSEY OUTCOMES: Clinical Endpoint Trial of Alirocumab
in Patients after Acute Coronary Syndrome (ACS)
SMART-DATE: Is 6 Months of DAPT Suffice after ACS-PCI?
TREAT: Ticagrelor vs. Clopidogrel after STEMI Thrombolysis
VEST: Discrepancy of "Vest"-Benefit in Post-Infarct Patients
with Reduced EF
COLUMNS
- Diabetes: Comparison of Alirocumab with Placebo in Patients with
Inadequately Controlled Lipids despite Maximum Administration
of Statins after Acute Coronary Syndrome (ODYSSEY Study1,2)
- Myocardial Ischemia: MINOCA/ INOCA: Myocardial Infarction/
Ischemia With Non-Obstructive Coronary Arteries
- Sports Medicine: Physical Fitness is Decisive for
Preventing Heart Failure
- Heart Failure: Pulmonary Vein Ablation – New Hope
for Heart Failure
CCN Number 4/2017
ePaper
CCN Number 4/2017
PDF (43 MB)
Number 4/2017
ABRIDGE-J: Less Bleeding with Paused Dabigatran
during AF Ablation
ABSORB IV: Results with Proper Implantation Technique
BRUISE CONTROL-2: Use of NOACs during Device Surgery
CULPRIT SHOCK: PCI in Cardiogenic Shock
DAPT-STEMI: 6 versus 12 Months of Dual Antiplatelet Therapy
Following DES Implantation in STEMI
DARE: Paclitaxel DEB vs. Everolimus DES for In-Stent Restenosis
RE-DUAL PCI Subgroups: ACS, Stent Type and Ticagrelor
SENIOR: Month DAPT Following DES with Stable CAD
TAVI COSTS: Cost-Effectiveness vs. Surgical Aortic Valve
Replacement in Patients at Moderate Risk for Surgery
COLUMNS
- Diabetes: Empagliflozin, the Risk of Cardiovascular Death
and Hospitalization due to Heart Failure in different
Stages of Heart Failure (EMPA-REG outcome study)
- ORBITA: A Very Controversial Study
on the Efficacy of PCI in Chronic Stable CAD
- Sports Medicine: The optimal Cardiovascular Diet:
Everything gets turned Upside Down
- Heart Failure: Acute Heart Failure and
Cardiogenic Shock
CCN Number 3/2017
ePaper
CCN Number 3/2017
PDF (50 MB)
Number 3/2017
BIOFLOW V: New PCI "Gold Standard" for DES?
CANTOS: Inhibition of Inflammation in Post-MI Patients
CASTLE-AF: Mortality Advantage due to Ablation of
Atrial Fibrillation in Patients with Heart Failure
COMPASS: Low-Dose Rivaroxaban in Patients
with Stable Cardiovascular Disease
DETO2X: No Routine Oxygen Administration in
Acute Myocardial Infarction
EMANATE-AF: Apixaban before and after Cardioversion
RACE-3: Upstream Therapy Reduces Atrial Fibrillation
RE-DUAL PCI: Fewer Bleeding Events in Dual Regime
with Dabigatran
REVEAL: Anacetrapib to Reduce Risk in Patients with
Overt Cardiovascular Disease
SPYRAL HTN-OFF MED: Renal Denervation in Arterial
Hypertension without Antihypertensive Medication
COLUMNS
- Diabetes: EXSCEL Study on the Cardiovascular Safety of
Exenatide (once weekly) in People with Type 2 Diabetes
- Myocardial Ischemia: SYNTAX II versus SYNTAX I:
Impact of Intracoronary Physiology on PCI Indication
- Sports Medicine: Physical Exercise after TAVI
- Heart Failure: Gene Therapy in Duchenne Muscular Dystrophy
CCN Number 2/2017
ePaper
CCN Number 2/2017
PDF (50 MB)
Number 2/2017
ACIST-FFR: Validation of a Universally Deployable
Compared with a Standard Pressure Wire
ADVANCE CoreValve: 5-year Results
AIDA: Late Thromboses after ABSORB Scaffold
are Independent of Vessel Size or Pretreatment
BIOSOLVE-II und –III: No Thromboses after 2 Years
for the MAGMARIS Completely Absorbable Coronary Stent
DESolve: No Thromboses after 5 Years for the ELIXIR
Completely Absorbable Coronary Stent
DISRUPT CAD: Lithoplasty for the Treatment
of Calcified Coronary Stenoses
EURO-CTO: Optimal Medical Therapy
vs. Revascularization in CTO
GUIDE-CRT: SPECT-Guided Implantation Better than
Routine Procedure
NODE-1: Nasal Spray for Termination of Tachycardia
POWDER-AF: Combination of Ablation and Medications
leads to High Success Rate in Atrial Fibrillation
TOPIC: DAPT with ASA + Prasugrel or ASA + Ticagrelor
for only 4 Weeks after ACS?
KONGRESS-NEWS (only in German)
COLUMNS
- Diabetes: Intestinal Microbiome and
Metabolic Conditions
- Mykoardischämie: Rationale for Discordances Between FFR
and CFR, or Noninvasive Ischemia Tests Respectively
- Sportmedizin: Physical Exercise with
Systolic Heart Failure
- Herzinsuffizienz: Type 1 Diabetes and Heart Failure
CCN Number 1/2017
ePaper
CCN Number 1/2017
PDF (49 MB)
Number 1/2017
ABSORB-III: 2-Year Results
DEFINE-FLAIR: Advantages of iFR vs. FFR in Deciding
on Coronary Revascularization
EBBINGHAUS: Evolocumab: No Effects
on Cognitive Function
EINSTEIN CHOICE: After Venous Thrombembolism,
Prolonged Therapy with Rivaroxaban is Superior to Aspirin
FOURIER: Evolocumab Reduces Cardiovascular Events
GEMINI-ACS1: Rivaroxaban is Equivalent to Aspirin after ACS
RE-CIRCUIT: Fewer Bleeding Events for AF Ablation
with Continued Dabigatran Administration
S-LAAO: Surgical Closure of the Left Atrial Appendage
Reduces Thrombembolic Risk
SPAIN: Closed-Loop Stimulation Effective in
Vasovagal Syncope
SURTAVI: TAVI vs. Surgery in Intermediate Operative Risk
SWEDEHEART: Better Tolerability of iFR vs. FFR-supported
Decision on Coronary Revascularization
COLUMNS
- Diabetes: Reduction of Cardiovascular Risk by
Lowering LDL with Evolocumab: Outcome study (Fourier)
- Myocardial Ischemia: DEFINE-FLAIR and iFR-Swedeheart:
iFR vs. FFR Outcome Trials
- Sports Medicine: Do Women also Get Athlete’s Heart?
- Heart Failure: Heart Failure with Preserved
Ejection Fraction HFpEF
CCN Number 4/2016
ePaper
CCN Number 4/2016
PDF (42 MB)
Number 4/2016
ABSORB-II: 3-Year Results for the Fully
Absorbable Stent (“Scaffold”)
ASSERT-II: Asymptomatic AF and Risk Profile
BIO-RESORT (TWENTE-III): Comparison of Absorbable
with Permanent Coating of DES
EMPA-REG OUTCOME CVD: Latest Data
EUCLID: Ticagrelor in Peripheral Artery Disease
EXCEL: PCI vs. Bypass Surgery in Left Main Stenosis
GLAGOV: Plaque Regression - PCSK9 Inhibitor Evolocumab
NOBLE: PCI vs. Bypass Surgery in Left Main Stenosis
PIONEER AF-PCI: New Strategies for Triple Therapy
RE-VERSE AD: Update on the Dabigatran Antidote
SENTINEL: Cerebral Protection During TAVI
WATCHMAN-USA: Safety of Interventional Closure
of the Left Atrial Appendage
KONGRESS-NEWS (only in German)
COLUMNS
- Diabetes: Empagliflozin and Progression of Nephropathy
in Type 2 Diabetes (EMPA-REG Outcome Study)
- Myocardial Ischemia: ISCHEMIA Trial is Seeking Additional
Sites in Germany
- Sports Medicine:Bicycling is Sufficient for
Cardiovascular Prevention
- Heart Failure: Heart Failure in Patients
with Diabetes Mellitus
CCN Number 3/2016
ePaper
CCN Number 3/2016
PDF (32,5 MB)
Number 3/2016
ABSORB-JAPAN-2-Year Results: Absorbable vs. Non-Absorbable
Everolimus-Eluting Coronary Stent
ANTARCTIC: Randomized Study of the Value of Platelet
Function Tests for Prasugrel in Elderly Patients
CE-MARC 2: MRI vs. SPECT vs. Standard Procedure in
Suspected CAD
DANISH: No Benefit from ICD in Non-Ischemic
Cardiomyopathy
ENSURE-AF: Edoxaban vs. Warfarin with Cardioversion
ESCAPE: Avoidance of Lipoprotein Apheresis in Heterozygous
Familial Hypercholesterolemia with Alirocumab
PEGASUS-STROKE: Prevention of Stroke with Ticagrelor
in Patients After Myocardial Infarction
REM-HF: Telemonitoring Superfluous in Heart Failure?
SAVE: CPAP in Patients with Obstructive Sleep Apnea
and Cardiovascular Disease
KONGRESS-NEWS (only in German)
COLUMNS
- Diabetes: Sustain 6: Study on Cardiovascular Safety
of Semaglutide in Patients with Type 2 Diabetes
- Myocardial Ischemia: CE-MARC 2: Stress NMR and SPECT Equally
Effective in Reducing Unnecessary Coronary Angiography Rate
- Do Statins Influence Physical Endurance?
- Heart Failure: Primary Therapy with Defibrillator in
dilatative Cardiomyopathy? DANISH Study
CCN Number 2/2016
ePaper
CCN Number 2/2016
PDF (39,5 MB)
Number 2/2016
BIOSOLVE-II: 1-Year Results for the
Absorbable Magnesium DES (Magmaris)
DCB-ONLY: Paclitaxel-eluting Balloon for PCI
of Native Coronary Stenoses
EFFORTLESS: Registry for Subcutaneous ICD Implantation
LAA-SURG: Surgical Removal of Left Atrial Appendage (LAA)
in Patients with Persistent AF
OASIS: Inferiority of Rotor-guided Ablation as Compared
to Conventional Ablation in Patients with AF
OPINION: Randomized Comparison of OCT-OFDI
vs. IVUS- guided PCI
PRESSURE: Routine Re-Ablation Following PVI
in Patients with Atrial Fibrillation
SMARTTOUCH: No improvement for
Contact Pressure-controlled Ablation in AF
SOURCE-3: TAVI with the SAPIEN 3 Valve
SYNTAX-II: 1 Month Results in Coronary 3-VD
COLUMNS
- Diabetes: GLP-1 Receptor Agonist Liraglutide Reduces
Cardiovascular Risk in Type 2 Diabetes
- Myocardial Ischemia: PROMISE: Outcomes of Anatomical versus
Functional Testing for Diagnostics of Coronary Artery Disease
- Sports Medicine:What Dose of Physical Activity is Optimal?
- Heart Failure: Anthracycline and Heart Failure
CCN Ausgabe 1/2016
ePaper
CCN Number 1/2016
PDF (44,5 MB)
Number 1/2016
ACCELERATE: Influence of the CETP Inhibitor Evacetrapib
on Cardiovascular Prognosis
ALPS: Benefit of Antiarrhythmic Agents in VF/VT-induced
Cardiac Arrest
CoreValve US Pivotal: Superiority of TAVI vs. Surgery Persists even in High-Risk Patients
EARLY-BAMI: Pre-Interventional Betablocker Administration
in STEMI
FIRE AND ICE: Cryoballoon vs. Radiofrequency Ablation for
Atrial Fibrillation
GAUSS-3: Evolocumab vs. Ezetimibe in Patients with
Statin-Associated Intolerance
PARTNER-2A INTERMEDIATE RISK: TAVI vs. Surgery
in Patients with Intermediate Surgical Risk
PEGASUS DIABETES: Long-Term DAPT with ASA and Ticagrelor
in Post-Infarct Patients
RATE vs. RHYTHM CONTROL: Comparison in Postoperative
Atrial Fibrillation
SAPIEN-3: TAVI vs. Surgical Aortic Valve Replacement
with Intermediate Surgical Risk
COLUMNS
- Diabetes: Pioglitazone Reduces Cardiovascular Events
After Ischemic Stroke or Transient Ischemic Attack (IRIS Study)
- Myocardial Ischemia: EVINCI: Allocation of Ischemic Segments
to True Coronary Vessel after Correction by Hybrid Imaging
- Sports Medicine:Physical Exercise Improves Coronary
Collateral Growth
- Heart Failure: Bypass Surgery and Ischemic Cardiomyopathy
CCN Ausgabe 4/2015
ePaper
CCN Number 4/2015
PDF (44,5 MB)
Number 4/2015
ABSORB III: Randomized Trial with a Clinical Endpoint
BIOSOLVE II: Completely Absorbable Magnesium Stent
CURRENT AS: Surgical versus Conservative Management of
Asymptomatic High-Grade Aortic Stenosis
DRAGON: Transradial vs. Transfemoral Access for PCI
EVITA: Varenicline for Nicotine Cessation in ACS
EWOLUTION: Watchman LAA Occluder Registry
LEADERS FREE: DES with Only 1 Month of DAPT
PARTNER II: TAVI After Surgical Aortic Valve Replacement
PEGASUS-STENT: Prognostic Gain in Secondary Prevention
with Ticagrelor is Independent of Stents
SPRINT: Optimal Target of Systolic Blood Pressure
VWQRSD: CRT, Right Bundle Branch Block and Very Wide QRS
COLUMNS
- Diabetes: Compared with Standard Therapy, Empagliflozin
Reduces Cardiovascular Risk and Mortality in Type 2 Diabetes
- Myocardial Ischemia: Macro- or Microvascular Ischemia
in SPECT? Clarification by Cardiac Hybrid Imaging
- Sports Medicine:Gait Speed is an independent Predictor
of Prognosis in Heart Failure
- Heart Failure: Blood Pressure and Heart Failure
CCN Number 3/2015
ePaper
CCN Number 3/2015
PDF (41,5 MB)
Number 3/2015
ABSORB JAPAN: Absorbable vs. Non-Absorbable Everolimus-Eluting Coronary Stent
BELIEF: Catheter Ablation with Isolation of LAA in Persistent Atrial Fibrillation
EAST-AF: No Benefit From Antiarrhythmic Drugs For 3 Months After Ablation in Atrial Fibrillation
EMPA-REG OUTCOME Trial with Empagliflozin:
First Time Mortality Reduction with an Antidiabetic Drug
LEADLESS II: Leadless Pacing - FDA Approval Study on the Safety and Efficacy of Nanostim Leadless Pacemaker
MANTRA-PAF 5-Jahresergebnisse: Comparison of Ablation vs. Antiarrhythmics in Atrial Fibrillation
ODYSSEY-4: Alirocumab vs. Placebo in Heterozygous Familial Hypercholesterolemia – 4 Studies
OPTIDUAL: 12- vs. 48-Months DAPT After DES
OPTILINK-HF: Telemedicine Monitoring in Heart Failure Patients with ICDs
PARAMETER: Angiotensin Receptor Neprilysin Inhibitor (ARNI) vs. Angiotensin Receptor Blockers in art. Hypertension
PEGASUS-INTERVAL: Extended DAPT with Ticagrelor as a Function of the Prior DAPT-free Interval
PLATFORM: FFRCT as Gatekeeper for Cardiac Catheterization
COLUMNS
- Diabetes: Safety of Incretin Therapy: New large Outcome Studies
– TECOS (Sitagliptin) and ELIXA (Lixisenatide)
- Myocardial Ischemia: FFRCT: Non-invasive Assessment
of FFR by Coronary CTA
- Sports Medicine: Physical training with ICD?
- Heart Failure: Servo-Ventilation Increases Mortality
in Heart Failure with Central Sleep Apnea
CCN Number 2/2015
ePaper
CCN Number 2/2015
PDF (41,5 MB)
Number 2/2015
BAT: Baroreflex Activation Therapy in Heart Failure
BVS-STEMI: Absorbable DES in STEMI
COREVALVE EVOLUT R: Repositionable TAVI Valve
DISCOVERY 1TO3: Stent Coverage by the Ultimaster DES
FREEZE-AF: Cryoballoon vs. Radiofrequency Ablation
HEARTLIGHT: Laser Balloon vs. Radiofrequency Ablation
ILUMIEN II: OCT- vs. IVUS-guided Stent Implantation
MICRA-TPS: Leadless Pacing - First Results
NOTION: All-Comer Study to Compare TAVI
with Aortic Valve Replacement (SAVR) in Aortic Stenosis
OPINION: OFDI- vs. IVUS-guided Stent Implantation
ProMRI: Safety of an ICD for Thoracic MRI
RESOLUTE-8000: Stent-Related vs. Patient-Related
Results after 5 Years with the Zotarolimus-DES
VENTURE-AF: Rivaroxaban during Ablation
COLUMNS
- Diabetes:New Basal Insulin with Greater
Safety due to Lower Risk of Hypoglycemia
- Myocardial Ischemia: ISCHEMIA-CKD: Chronic Kidney Disease
increases the Risk to die of a Heart Attack
- Sports Medicine:Physical Exercise for ICD Patients
- Heart Failure: Stroke and Heart Failure
CCN Number 1/2015
ePaper
CCN Number 1/2015
PDF (23 MB)
Number 1/2015
AATAC: Ablation vs. Amiodarone in Patients with Persistent Atrial Fibrillation and Heart Failure
BEST: Everolimus-eluting DES vs. Bypass Surgery
CoreValve US Pivotal 2-Jahresergebnisse: Superiority
of TAVI vs. Surgery Maintained in High-Risk Patients
CTSN-AF: Should Patients with Atrial Fibrillation undergo
Surgical Ablation during Mitral Valve Surgery?
DEFLECT III: Cerebral Embolic Protection in TAVI
LEGACY: Weight Reduction and Atrial Fibrillation
OSLER: Significant LDL Cholesterol Reduction
with the PCSK9 Inhibitor Evolocumab
PARTNER II: First 30-days Outcomes for TAVI with SAPIEN 3
PEGASUS: Secondary Prevention with Ticagrelor
PROMISE: Anatomical vs. Functional Diagnostic
in Symptomatic Patients with Suspected CAD
TOTAL: No Routinely Thrombus Aspiration in STEMI
PRODUCT NEWS: Risk of Stent Thrombosis Significantly Lower
than Prejudice Claims
COLUMNS
- Diabetes:Synergistic Effects of Insulin with
Incretin-based Therapy
- Mykoardischämie: ISCHEMIA Trial: German Sites
To Date Underrepresented
- Sportmedizin:The importance of a healthy lifestyle
in the prevention of cardiovascular disease
- Herzinsuffizienz: Hypertrophic Cardiomyopathy as
“Model Disease” of Diastolic Heart failure
CCN Number 4/2014
ePaper
CCN Number 4/2014
PDF (53 MB)
Number 4/2014
ABSORB II: First Randomized Study of an Absorbable Scaffold
AVOID: No Routine Oxygen Administration in STEMI
BRIGHT: Bivalirudin vs. Heparin vs. Heparin + Tirofiban
in Primary PCI
CLEAN-TAVI: Cerebral Embolic Protection for TAVI
DAPT: How long after Stent Implantation?
EXCITE ISR: Excimer Laser Atherectomy vs. PTA
for Femoropopliteal In-Stent Restenosis
IMPROVE-IT: Improvement of Prognosis after Myocardial
Infarction by Additional Administration of Ezetimibe
ISAR TRIPLE: 6 Weeks or 6 Months of Triple Therapy?
REPRISE-II: 1-Year Results with the Lotus TAVI System
RIBS IV: Paclitaxel-eluting Balloon versus Everolimus-
Eluting Stent for In-Stent Restenosis of DES
SECURITY: 6 Months vs. 12 Months DAPT after DES
SYMPLICITY FLEX: Randomized Study of Renal
Denervation for Mild Arterial Hypertension
COLUMNS
- Diabetes:Does Statin Therapy Induce Type 2 Diabetes
as a „Side Effect“?
- Myocardial Ischemia: ISCHEMIA-CKD: Substudy
Launched in Germany
- Sports Medicine:Blood Pressure Progression during Aging:
The Importance of Physical Fitness
- Heart Failure: Cardiac Resynchronization – a Milestone
in Heart Failure Therapy
CCN Number 3/2014
ePaper
CCN Number 3/2014
PDF (35 MB)
Number 3/2014
ATLANTIC: Ticagrelor for STEMI already in Ambulances?
BIOPACE: Is Biventricular Pacing in AV Block required
to prevent Cardiac Desysnchronization?
BIOSCIENCE: ORSIRO vs. XIENCE PRIME
CONFIRM-HF: Intravenous Ferric Carboxymaltose
in Patients with Heart Failure and Iron Deficiency
LISTEN: Advantages of Rosuvastatin in Diabetes Mellitus?
ODYSSEY COMBO II: PCSK9 Inhibition with Alirocumab for
inadequately controlled Hypercholesterolemia
PARADIGM-HF: Angiotensin Receptor-Neprilysin
Inhibition (ARNI) in Chronic Heart Failure
RE-LY: Post-hoc Analysis of the Influence of Dabigatran
vs. Warfarin on Renal Function
SIGNIFY: Effect of Ivabradine on the Prognosis in Patients
with Coronary Artery Disease without Heart Failure
STAR AF: Optimal Ablation Strategy in Atrial Fibrillation?
XVeRT: Rivaroxaban for Cardioversion
INTERVIEW: With Prof. Christoph Bode
COLUMNS
- Diabetes:Empagliflozin vs. glimepiride as add-on medication
to metformin: two-year comparative study
- Myocardial Ischemia: Incomplete Revascularisation after PCI
or CABG – Frequency and Prognostic Relevance
- Sports Medicine:How Much Activity is Enough to Extend Life?
- Heart Failure: Diastolic Heart Failure – The Search for
Effective Pharmacological Therapy
CCN Number 2/2014
ePaper
CCN Number 2/2014
PDF (34 MB)
Number 2/2014
ABSORB FIRST: Short-Term Results of a Registry
for Absorbable Scaffolds
APPOSITION IV: Self-Expanding Coronary Stent
in Acute Myocardial Infarction
BABILON: Drug-eluting Balloon for Bifurcated Lesions
CENTURY II: The New Ultimaster DES
with an Absorbable Polymer
IBERIA REGISTE: 2-Year Results after LAA Occlusion
JUPITER:Short-Term Results for the 2nd Generation
TAVI with JENAVALVE
OCTAVIA:Are there different Mechanisms
of Myocardial Infarction in Women?
PRAGUE 16:Direct Thrombus Aspiration in Acute Stroke
PREDICTORS of Nonresponse to RDN
RESOLUTE ALL COMERS:5-Year Results
SAPIEN 3 TAVI:First Short-Term Results
COLUMNS
- Diabetes:Triple combination of saxagliptin/dapagliflozin/
metformin for better glycemic control
- Mykoardischämie: Is Exercise ECG testing still up to date
for decision-making in interventional cardiology?
- Sportmedizin:LV Trabeculation in the Athlete’s Heart
and Differentiation from Non-Compaction Cardiomyopathy
- Herzinsuffizienz: Many in-patient heart failure treatments
are costly, but preventable
CCN Number 1/2014
ePaper
CCN Number 1/2014
PDF (34 MB)
Number 1/2014
ALECARDIO: Cardiovascular Events after Acute Coronary
Syndrome on Treatment with Aleglitazar
CHOICE: Comparison of TAVI with COREVALVE vs. SAPIEN XT
COREVALVE US: First Randomized Comparison of TAVI
with the CoreValve vs. Surgical Aortic Valve Replacement
CORP-2: Randomized Study for the Treatment of
Recurrent Pericarditis with Colchicine
GAUSS-2: Evolocumab in Hypercholesterolemic Patients
Unable to Tolerate an Effective Dose of Statin
GLOBAL SYMPLICITY REGISTRY: Renal Denervation
under Everyday Conditions
HEAT PPCI: Bivalirudin versus Heparin in STEMI
SYMPLICITY HTN-3: Randomized Trial of Renal
Denervation in Uncontrolled Arterial Hypertension
TVT US: 1-Year Data from the US TAVI Registry
ZEUS: ENDEAVOR DES in Patients with Short DAPT Duration
COLUMNS
- Diabetes: Reduction of the Cardiovascular Risk Profile in
Type 2 Diabetes: Effects of Treatment with SGLT2 Inhibitors
- Mykoardischämie: ISCHEMIA Trial –
First Enrollment in Germany
- Sportmedizin:Sport as a Promoter
of ARVC Manifestation
- Herzinsuffizienz: Medical Care Situation in Germany
CCN Number 4/2013
ePaper
CCN Number 4/2013
PDF (20 MB)
Number 4/2013
ADVISE II: FFR Possible Without Adenosine?
DUTCH PEERS (TWENTE II): Resolute Integrity vs. Promus Element
EUROMAX: Superiority of Bivalirudin vs. Heparin ± GPI in STEMI
HYBRID: Randomized Comparison of Coronary
Hybrid Revascularization with Standard Bypass Surgery
LEVANT II: Randomized Comparison of PTA of the Femoropopliteal
Arteries with DEB vs. Simple Balloon
MASTER: 1-Year Results
OPTIMIZE: 3 vs. 12 Months of DAPT
PLATINUM PLUS: Randomized DES Comparison
of Promus Element vs. Xience Prime
REGADENOSON MAX: Maximal Myocardial Ischemia
Compared with Adenosine
REPRISE II: Registry Study of the LOTUS Repositionable TAVI Valve
RIBS V: SeQuent Please Balloon vs. Xience Prime Stent
for In-Stent Restenosis
SORT OUT VI: Resolute Integrity vs. Biomatrix Flex in “All Comers”
PRODUCT NEWS: BIOTRONIK announces CE mark for PK Papyrus covered Coronary Stent for Treatment of Coronary Artery Perforation
COLUMNS
- Diabetes:Common ESC and EASD Guideline on Diabetes,
Pre-Diabetes and Cardiovascular Illnesses
- Myocardial Ischemia:Improved Non-Invasive
Ischemia Diagnosis using Hybrid Imaging
- Sports Medicine:The Influence of Cardiorespiratory Fitness
on Morbidity and Mortality after Bypass Surgery
- Heart Failure:Should we Abandon Non-Steroidal Antiphlogistics
(NSAIDs) in Heart Failure?
CCN Number 3/2013
ePaper
CCN Number 3/2013
PDF (20 MB)
Number 3/2013
ACCOAST: First Randomized Study on Pretreatment with
an Oral Antiplatelet Medication for PCI in NSTEMI
DECAAF: MRI-Controlled Fibrosis Ablation Instead of Vein Isolation?
ECHO-CRT: No CRT for Narrow QRS Complex Despite Dyssynchrony
HOKUSAI: Edoxaban vs. Warfarin for the Treatment
of Acute Symptomatic Venous Thromboembolism (VTE)
ORIGIN: Does Hypoglycemia Increase the Cardiovascular Risk?
RE-ALIGN: Dabigatran vs. Warfarin in Patients with
Mechanical Heart Valves
SAVOR-TIMI 53: Saxagliptin and Cardiovascular Outcome
TAO: Otamixaban in Patients with NSTE-ACS PCI
TASTE: Insufficient Effectiveness of Thrombus Aspiration for STEMI
INTERVIEW: Less is More! Pretreatment with ADP Antagonists
not Necessary for NSTEMI
PRODUCT NEWS: IN-TIME: Survival Benefit for Heart Failure
Patientswith Remote Monitoring
COLUMNS
- Diabetes:Early Entry with Basal Insulin in Type 2 Diabetes
- Myocardial Ischemia:iFR instead of FFR measurement: easier
functional assessment of coronary lesions
- Sports Medicine:Typical ECG findings for „Athlete‘s heart“
- Heart Failure:High sensitive Troponins –
Key Biomarkers not only in Acute Coronary Syndromes
CCN Number 2/2013
ePaper
CCN Number 2/2013
PDF (30 MB)
Number 2/2013
ADVANCE COREVALVE: 1-Year Results
ADVISE II: Functional Assessment
of Coronary Stenosis without Adenosine
BIOFLOW-II: Orsiro vs. Xience Prime DES
DESOLVE: A New Bioresorbable Scaffold
ELISA-3: Early or Late Intervention
in High-Risk Patients with NSTE-ACS?
NEXT + COMPARE-II: Combined Analysis of Two Studies
REDUCE HTN: Renal Denervation with the Vessix System
REPRISE I: 1-Year Results for the Lotus TAVI
RESOLUTE BIFURCATION: 3-Year Results with
the Resolute DES in Patients with Bifurcation Lesions
RIPCORD: How does FFR Affect Decisions in Real Practice
COLUMNS
- Diabetes: The LOOK AHEAD Study
- Myocardial Ischemia: FFR in the German DRG-System:
Paradox between Evidence and Reimbursement
- Sports Medicine: Physical Home-based Exercise for Patients
with Peripheral Arterial Disease
- Heart Failure: Does Serial Determination of Natriuretic
Peptides improve the Treatment?
CCN Number 1/2013
ePaper
CCN Number 1/2013
PDF (22 MB)
Number 1/2013
ADAPT-DES: IVUS for Reducing Stent Thrombosis
ARMYDA 9 Carotid: Clopidogrel and Atorvastatin for Carotid PTA
CHAMPION PHOENIX: Cangrelor compared to Clopidogrel for PCI
DAPT-RESOLUTE: Only 1 Month of Dual Antiplatelet Therapy?
DES LATE: Optimal Duration for Clopidogrel
Administration Following Stent Implantation
GARY: German Aortic Valve Registry: 1-year results
NEXT: Equivalence of Nobori and Xience/Promus DES
PLATO NSTE-ACS: A Ticagrelor vs. Clopidogrel Subgroup Analysis
REGADENOSON-SPECT: Prognostic Value of Regadenoson
Myocardial Perfusion Scintigraphy in Elderly Patients
STREAM: Early Administration of Tenecteplase for STEMI
INTERVIEW
Functional impact of contrast media during Cardiac Catheterizations
INDUSTRY
Intravenous Cangrelor is effective (in German only)
COLUMNS
- Diabetes: Combination therapy with niacin
in high cardiovascular risk
- Myocardial Ischemia: Pharmacological Stress
in Multimodal Cardiac Ischemia Diagnosis
- Sports Medicine: Atrial fibrillation in older athletes
- Heart Failure: structure and aims of the Comprehensive
Heart Failure Center (CHFC) Würzburg
CCN Number 4/2012
ePaper
CCN Number 4/2012
PDF (43 MB)
Number 4/2012
ADAPT-DES: Inadequate clopidogrel effect
ETAP: Stenting of the popliteal artery
iFR: FFR equivalent without adenosine infusion
ISAR-DESIRE 3: Comparison of DEB with DES
for „Limus“ stent restenosis
SAR-LEFT MAIN-2: Comparison of Resolute and Xience
for PCI of unprotected left main stem stenosis
MASTER: A mesh-based embolic protection system
for primary PCI in STEMI
PC: Closure of a patent foramen ovale ineffective?
RESOLUTE 3 years: Persistent long-term results for the
comparison of the Resolute with the Xience stent
RESPECT: Stroke prophylaxis by PFO closure:
Intention-to-treat or per protocol analysis?
STEMI RADIAL: Bleeding rates after radial or
femoral access for PCI in STEMI
TRILOGY-ACS Angio: Subgroup analysis with
versus without cardiac catheterization
XIMA: BMS versus DES in patients over 80 years
INTERVIEW
Start ivabradine as soon as possible!
PRODUCT NEWS
- Boston Scientific acquires Vessix Vascular
- Safe long-term data for dabigatran (In German only)
- Positive results for Pantera Lux balloon catheter
- The RESOLUTE clinical program: 1 month DAPT
COLUMNS
- Diabetes: Bypass surgery of coronary multivessel
disease more successful than stent implantation
- Myocardial Ischemia: Ranolazine: an additional option
- Sports Medicine: Optimal training intensity?
- Heart Failure: Palliative concepts are lacking
CCN Number 3/2012
ePaper
CCN Number 3/2012
PDF (115 MB)
Number 3/2012
ACCESS-EUROPE: 1-Year Results for the MitraClip
AFA Pilot: Registry for the ablation of atrial fibrillation
FAME II: Prognostic benefit of PCI with FFR in stable CAD
IABP-SHOCK II: No benefit of the IABP for infarction and cardiogenic shock
JenaValve TAVI: First Results of the Registry
PROTECT: First randomized trial regarding late stent thrombosis
RE-LY AF Registry: Global assessment of stroke and mortality
in patients with atrial fibrillation
SHIFT: New clinical perspectives
TRILOGY: Conservative approach with Prasugrel in ACS
WOEST: First randomized trial comparing an antithrom- botic triple vs. dual therapy after stent implantation
PRODUCT NEWS
- Targeted Implantation of Cardiac Pacemakers for Neurocardiogenic
Syncopes improves Clinical Outcome (German only)
- New BIOTRONIK ICD and CRT-D Series
Gives Patients First-Ever Access to MR Scans
- COMBO Dual Therapy Stent TM - Delaid vascular healing process
for drug- eluting stents (German only)
COLUMNS
- Diabetes: The „Obesity Paradox“ Myocardial“
- Ischemia: Ischemia-driven revascularization
in patients with chronic stable CAD
- Sports Medicine: Physical activity: A must with diabetes!
- Heart Failure: Post-Inpatient care in heart failure –
how can our healthcare system cope?
CCN Number 2/2012
ePaper
CCN Number 2/2012
PDF (134 MB)
Number 2/2012
APPOSITION-III: Stentys DES in Patients with STEMI
BIOSOLVE-I: First Results with a Paclitaxel-eluting
Absorbable Magnesium Stent
COMFORTABLE AMI: Biomatrix DES vs. BMS in STEMI
COMPARE-II: Xience / Promus DES vs. Nobori DES
in „everyday patients“
EVOLVE-I: 12-month data for the SYNERGY DES
MICAMI: Mesh-based Embolic Protection
in STEMI with the MGuard system
RESOLUTE Bifurcations: pooled analysis from two studies of the RESOLUTE Global Programm
SORT OUT V: Nobori DES vs. Cypher DES
SOURCE XT: TAVI with the SAPIEN XT Valve
30-day results
TRIPLET: Prasugrel loading dose following a loading dose of Clopidogrel
PRODUCT NEWS
- Approve Sapien TAVR FDA advisors say
- NOBORI-2 Registry confirms DES (in German only)
- Dabigatran for patients with mechanical heart valves
COLUMNS
- Diabetes: ORIGIN
- Myocardial Ischemia: FAME-II
- Sports Medicine: HERITAGE
- Heart Failure: new ESC Guidelines
CCN Number 1/2012
ePaper
CCN Number 1/2012
PDF (154 MB)
Number 1/2012
BELLO: the IN.PACT Falcon DEB vs. Taxus DES for the
Treatment of de-novo Coronary Lesions
BRAVO: Bivalirudin and UFH
for Aortic Balloon Valvuloplasty
FEATHER: Prasugrel 5 mg vs. 10 mg
INFUSE-AMI: Abciximab and/or Thrombus
Aspiration in Anterior STEMI
PARTNER COHORT A: 2 year results: TAVI vs. Surgery
PATRAS: Ticagrelor vs. Prasugrel
PLATINUM 2 year results: Promus Element vs.
Promus/Xience V Everolimus-DES
VALENTINES-II: The Dior-II Drug-eluting Balloon for the
Treatment of de-novo Coronary Lesions
JUST PUBLISHED:
- Myocardial Infarction in RE-LY
- DEB Cost/Effectiveness Analysis
PRODUCT NEWS:
- Ivabradine for Heart Failure (in German only)
COLUMNS:
- Diabetes up-to-date (in German only)
- Myocardial Ischemia up-to-date (in German only)
- Sports Medicine up-to-date (in German only)
- Heart Failure up-to-date (in German only)
BIK INFORMATIONS:
- DES and DEB: up-to-date Evaluation
- Heart Days / POCKET compendium (in German only)
CCN Number 3/2011
ePaper
CCN Number 3/2011
PDF (182 MB)
Current Cardiovascular News
Number 3/2011
ADDITIONS: Ivabradine for stable angina pectoris
ATLAS: Rivaroxaban also effective in ACS
DEAR: DIOR-II DEB in Patients with Diabetes Mellitus
DELUX: International Registry for the Pantera Lux DEB
EVOLVE: SYNERGY Stent vs. PROMUS Element
ISAR-REACT 4: Bivalirudin vs. Abciximab in NSTEMI-PCI
LEADERS 4 Jahre: Biomatrix Flex vs. Cypher
MERIT 1+2: BioMime Sirolimus-DES Registry Studies
PARTNER B: 2-year results
PEPCAD-DES: SeQuent Please DEB for DES-ISR
PEPPER: Pantera Lux DEB for ISR after BMS or DES
PLATINUM LL: Long Lesion Registry Study
PLATO-STEMI: differentiated Subgroup Analysis
REMEDEE: a new Combo-DES compared with Taxus
RESOLUTE-DIABETES: the Resolute DES in Diabetes Mellitus
SEQUENT PLEASE WWR: a World Wide Registry
BIK Information
– DES and DEB: up-to-date Evaluation (in German only)
CCN Number 2/2011
ePaper
CCN Number 2/2011
PDF (37 MB)
Current Cardiovascular News
Number 2/2011
ARISTOTLE: Apixaban vs. Warfarin in Atrial Fibrillation
BISOSOLVE-I: The first Drug-eluting absorbable Metal Stent
dal-PLAQUE: Effects of Dalcetrapib on Atherosclerosis
EXAMINATION: Xience-V Stent in STEMI Patients
PLATO-ST: Stent Thrombosis with Ticagrelor vs. Clopidogrel
RELY-AP: Antiplatelet Therapy and Dabigatran vs. Warfarin
RESOLUTE-OCT: Resolute DES vs. Xience-V DES
ROCKET AF-renal: Rivaroxaban vs. Warfarin in Pats with Atrial Fibrillation and Renal Insufficiency
SHIFT-ECHO: The Effect of Heart Rate Reduction with Ivabradine on Left Ventricular Remodeling
BIK introduces itself (in German only)
BIK Information
– New ESC Guidelines upgrade Prasugrel
– High estimated number of undetected diabetics
– German Foundation for the Chronically Ill
p-c-i live 2011 in Munich: Program
CCN Number 1/2011
ePaper
CCN Number 1/2011
PDF (37 MB)
Current Cathlab News
Number 1/2011
HABARA: The SeQuent Please Drug-eluting Balloon for the treatment of Sirolimus-DES in-Stent Restenoses
PARTNER-Cohort A: Comparison of TAVI with Surgery in severe Aortic Valve Stenosis
PEPPER: The Pantera Lux Drug-eluting Balloon for the Treatment of In-Stent Restenoses of BMS or DES
PLATINUM: Promus Element (Platinum-Chromium) vs. Promus/Xience V (Cobalt-Chromium) Everolimus-DES
RESOLUTE All Comers – 2-year results: Equivalence of Resolute and Xience V DES
SPIRIT III+IV: The Xience V Drug-eluting Stent for small Coronary Vessels
VALENTINES: The Dior-II Drug-eluting Balloon for the Treatment of BMS or DES In-Stent Restenoses
CONSENSUS-GROUP: For Drug-Eluting Balloons for in-stent restenoses, small vessels and bifurcation lesions (only in German)
BIK introduces itself (only in German)